Latest news
Oculis to Acquire Full Global Rights to Privosegtor from Accure Therapeutics in Strategic Asset Purchase - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 07:10:00 GMTOculis Receives Positive FDA Feedback for Privosegtor Development in Acute Multiple Sclerosis Relapses - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 08:10:00 GMT